Lipid 5

Ionizable lipids are formulated alongside other lipid components to construct lipid nanoparticles (LNPs), which serve as the primary non-viral delivery system for RNA-based therapeutics. A key feature of LNPs containing Lipid 5 was their rapid systemic clearance, which contributed to a favorable safety profile and minimal observed toxicity. Lipid 5 was specifically noted for its superior intravenous delivery efficiency to the liver. This is a reagent-grade substance intended exclusively for research applications.

2089251-33-0

Heptadecan-9-yl 8-((2-hydroxyethyl)(8-(nonyloxy)-8-oxooctyl)amino)octanoate; LIPIDV 004; Nonyl 8-[(8-heptadecan-9-yloxy-8-oxooctyl)-(2-hydroxyethyl)amino]octanoate; SCHEMBL18641619; 1-Octylnonyl 8-[(2-hydroxyethyl)[8-(nonyloxy)-8-oxooctyl]amino]octanoate

C₄₄H₈₇NO₅

710.18

InChI=1S/C44H87NO5/c1-4-7-10-13-16-25-32-41-49-43(47)35-28-21-17-23-30-37-45(39-40-46)38-31-24-18-22-29-36-44(48)50-42(33-26-19-14-11-8-5-2)34-27-20-15-12-9-6-3/h42,46H,4-41H2,1-3H3

ABCVHPIKBGRCJA-UHFFFAOYSA-N

Min 95%

Dried by centrifugal evaporation from a solution.

Conforms to structure

Store at -20°C for long term storage.